PedAM
Pediatric Disease Annotations & Medicines
| Disease | leukemia |
| Symptom | C0005699|blast crisis |
| Sentences | 24 |
| PubMedID- 23626851 | The human leukemic cell lines, k562 (blast crisis of chronic myeloid leukemia), hl60 (promyelocytic leukemia), molm14 (monocytic leukemia), nb4 (promyelocytic leukemia), jurkat (t-lymphoblastic leukemia), and raji (b-lymphoblastic leukemia), were maintained in rpmi 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (fcs) and antibiotics (100 u penicillin/ml and 100 μg streptomycin/ml) at 37°c in a humidified 5% co2 atmosphere. |
| PubMedID- 23899072 | We describe such a case of chronic myelogenous leukemia in blast crisis in a previously healthy 61-year-old woman. |
| PubMedID- 26155548 | Novel cytogenetic aberrations in a patient of chronic myeloid leukemia with blast crisis. |
| PubMedID- 25814082 | Management of chronic myeloid leukemia in blast crisis. |
| PubMedID- 23826587 | Pediatric chronic myeloid leukemia with b-cell lymphoid blast crisis at presentation. |
| PubMedID- 23056396 | The imatinib and nilotinib-sensitive bcr/abl+ k562, lama-84 and cml-t1 cell lines (blast crisis of human chronic myeloid leukemia, purchased from dsmz, braunschweig, de) were used in this study. |
| PubMedID- 22792345 | The demethylating drug has been shown to be effective in treating patients with myelodysplastic syndrome (mds) and blast crisis of chronic myelogenous leukemia (cml-bl) , . |
| PubMedID- 22176774 | The hematological and clinical parameters were consistent with aml-m4 e0 that resembles blast crisis of chronic myeloid leukemia (cml). |
| PubMedID- 21510902 | The imatinib-sensitive bcr/abl+ cml-t1 cell line (t-lineage blast crisis of human chronic myeloid leukemia, purchased from dsmz, braunschweig, de) was used to perform synergism studies. |
| PubMedID- 25789076 | Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: a case report. |
| PubMedID- 24371785 | The diagnosis was extramedullary myeloid blast crisis of chronic myelogenous leukemia (cml). |
| PubMedID- 25933373 | Chronic myeloid leukemia in blast crisis (cml bc) remains a challenging disease to treat despite the introduction and advances in tyrosine kinase inhibitor (tki) therapy. |
| PubMedID- 24330849 | Transduction of primary blast cells from chronic myeloid leukemia in blast crisis (cml-bc) and ph-positive acute lymphoblastic leukemia (all) with p16(ink4a) or p14(arf) virus also resulted in cell growth inhibition and/or apoptosis with a patient-to-patient variation, whereas clonal growth and differentiation of cord blood progenitor cells were not affected by enforced expression of ink4a/arf. |
| PubMedID- 26411119 | Characteristics and outcomes of patients with chronic myelogenous leukemia in blast crisis. |
| PubMedID- 22564882 | Another reason for enhanced pi3k/akt/mtor signaling in ph+ b-all is due to the fact pp2a is functionally inactivated during the blast crisis of chronic myelogenous leukemia through the inhibitory activity of set protein, which is regulated by bcr-abl . |
| PubMedID- 21698118 | The human nk-sensitive k562 (chronic myelogenous leukemia in blast crisis) and u-937 (acute myeloid monocytic leukemia) cell lines were used as target cells. |
| PubMedID- 25688862 | K562 cell is a bipotent cell line established from a patient in a blast crisis of chronic myeloid leukemia, it possesses variable capacities of differentiation toward erythroid and megakaryocytic cell lineages. |
| PubMedID- 24455663 | He was admitted with a provisional diagnosis of acute myeloid leukemia in blast crisis. |
| PubMedID- 26199254 | Here, we report of a patient with chronic myelogenous leukemia in blast crisis and with pulmonary failure due to leukostasis who recovered after a combination therapy of leukapheresis and imatinib treatment. |
| PubMedID- 22873358 | Human jurl-mk2 chronic leukemia in blast crisis cell line (dsmz, germany) was used as a positive control for mick assays performed with patient tumor cells. |
| PubMedID- 26024531 | Human jurl-mk2 chronic leukemia in blast crisis cell line (dsmz, germany) is used as a positive control for mick assays performed with patient tumor cells. |
| PubMedID- 22606423 | They rarely present with relapse of leukemia, in blast crisis of myeloproliferative disorder, as leukemic transformation in myelodysplastic syndrome 1. |
| PubMedID- 24486648 | Hes1 upregulation contributes to the development of fip1l1-pdgra-positive leukemia in blast crisis. |
| PubMedID- 25860287 | Cml-bc: chronic myeloid leukemia in blast crisis. |
Page: 1